Inventor
NAJIM JOHN
US23 patents
Patents
23 patentsUS11771776B2Oct 3, 2023
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC32 citations98
US11759525B1Sep 19, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC32 citations98
US11679161B2Jun 20, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC38 citations98
US11672872B2Jun 13, 2023
Anti-transferrin receptor antibody and uses thereof
DYNE THERAPEUTICS INC37 citations98
US11648318B2May 16, 2023
Anti-transferrin receptor (TFR) antibody and uses thereof
DYNE THERAPEUTICS INC37 citations98
US11638761B2May 2, 2023
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC47 citations98
US12239717B2Mar 4, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC13 citations94
US12239716B2Mar 4, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC13 citations94
US12144867B2Nov 19, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC14 citations94
US12144868B2Nov 19, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC14 citations94
US12102687B2Oct 1, 2024
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC17 citations94
US11986537B2May 21, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC24 citations94
US11969475B2Apr 30, 2024
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC25 citations94
US11844843B2Dec 19, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC30 citations94
US11839660B2Dec 12, 2023
Anti-transferrin receptor antibody and uses thereof
DYNE THERAPEUTICS INC30 citations94
US11633498B2Apr 25, 2023
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC37 citations94
US11931421B2Mar 19, 2024
Muscle targeting complexes and formulations for treating myotonic dystrophy
DYNE THERAPEUTICS INC26 citations92
US12329824B1Jun 17, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC4 citations86
US12128109B2Oct 29, 2024
Muscle targeting complexes and formulations for treating dystrophinopathies
DYNE THERAPEUTICS INC17 citations82
US12440575B2Oct 14, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12403203B2Sep 2, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12397062B2Aug 26, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12440574B2Oct 14, 2025
Muscle targeting complexes and formulations for treating myotonic dystrophy
DYNE THERAPEUTICS INC0 citations61